TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation
Immunology Letters · 2023-03 · 255 · 32-39
DOI: 10.1016/j.imlet.2023.02.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology Letters, 2023-03. Verfasst von Shouzhi Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Proctology, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Proctology, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China.
- Department of Geriatrics, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China.
- Department of Geriatrics, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China. Electronic address: mimigirls@sina.com.
Zitieren
APA
Zhou, S., Yang, Z., Liu, J., & Ran, M. (2023). TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation. Immunology Letters, 255, 32-39. https://doi.org/10.1016/j.imlet.2023.02.005
Vancouver
Zhou S, Yang Z, Liu J, Ran M. TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation. Immunology Letters. 2023;255:32-39. doi:10.1016/j.imlet.2023.02.005
BibTeX
@article{Zhou2023,
author = {Zhou, Shouzhi and Yang, Zhao and Liu, Jiaxin and Ran, Maojuan},
title = {TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation},
journal = {Immunology Letters},
year = {2023},
volume = {255},
pages = {32--39},
doi = {10.1016/j.imlet.2023.02.005}
}
EUVIMED